ZHENGGUANG(SZ:301092)2025-05-22 14:13Financial Performance - The company achieved an operating income of 57,183.90 million yuan in 2024, an increase of 8.67% compared to the previous year [4] - The net profit attributable to shareholders decreased by 5.33% to 10,299.55 million yuan [4] - The net profit after deducting non-recurring gains and losses fell by 5.72% to 8,770.55 million yuan [4] Project Development - The Jingmen project is expected to start trial production by the end of 2025 and reach operational status by the end of April 2026 [2] - The company is enhancing its sales force and market preparation for the Jingmen project [2] Industry Outlook - The demand for ion exchange and adsorption resins is increasing due to their applications in various sectors, including high-end industrial water, food and drinking water, nuclear industry, electronics, biomedicine, environmental protection, and new energy [3] - The company aims to become an "international first-class manufacturer of ion exchange and adsorption resins" by focusing on market demand, customer service, and technological innovation [5] Market Strategy - The company plans to strengthen its market layout and expand into high-margin product areas, including life sciences, semiconductors, and nuclear-grade resins [5] - The company is committed to maintaining product quality and optimizing product structure to address international competition and price wars [5] Research and Development - As of December 31, 2024, the company holds 22 patents, including 14 invention patents and 8 utility model patents [10] - The company is focusing on developing high-value-added products in the biomedicine sector, including immobilized enzyme carriers and solid-phase synthesis carriers [7] Customer Base - The company's products are sold not only in the domestic market but also in countries such as Germany, Switzerland, Russia, Italy, South Korea, the United States, and various regions in Africa [9] - Major clients include well-known companies like BRITA, Mitsubishi Chemical, Aquis, and China National Nuclear Corporation [11] ESG and Social Responsibility - The company emphasizes ESG development and aims to integrate sustainable development concepts into daily operations [12] - In 2024, the company participated in charitable activities and plans to continue its focus on social responsibility [12] Investor Relations - The company prioritizes communication with investors through various channels, ensuring transparency and timely information disclosure [13]